These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17596569)

  • 21. Toward increased sensitivity and specificity in the treatment of neoplastic diseases.
    Slavkin HC
    J Am Dent Assoc; 1998 Apr; 129(4):473-8. PubMed ID: 9573699
    [No Abstract]   [Full Text] [Related]  

  • 22. Keys to unlock cancer: targeted therapy.
    Viele CS
    Oncol Nurs Forum; 2005 Sep; 32(5):935-40. PubMed ID: 16136192
    [No Abstract]   [Full Text] [Related]  

  • 23. Macromolecules as taxane delivery systems.
    Dosio F; Stella B; Arpicco S; Cattel L
    Expert Opin Drug Deliv; 2011 Jan; 8(1):33-55. PubMed ID: 21142695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel agents target existing tumor vasculature.
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):303. PubMed ID: 20235388
    [No Abstract]   [Full Text] [Related]  

  • 25. Active targeting schemes for nanoparticle systems in cancer therapeutics.
    Byrne JD; Betancourt T; Brannon-Peppas L
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
    Abu Lila AS; Ishida T; Kiwada H
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the targeted delivery of theranostic carbon nanotubes have potential as a valid anticancer strategy?
    Das M
    Ther Deliv; 2014 Jan; 5(1):1-5. PubMed ID: 24341809
    [No Abstract]   [Full Text] [Related]  

  • 28. [Targeted anticancer drugs and their development].
    Kervinen J; Gahmberg CG
    Duodecim; 2004; 120(19):2323-30. PubMed ID: 15565985
    [No Abstract]   [Full Text] [Related]  

  • 29. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumour and dendrimers: a review on drug delivery aspects.
    Agarwal A; Asthana A; Gupta U; Jain NK
    J Pharm Pharmacol; 2008 Jun; 60(6):671-88. PubMed ID: 18498702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric drug delivery systems for localized cancer chemotherapy.
    De Souza R; Zahedi P; Allen CJ; Piquette-Miller M
    Drug Deliv; 2010 Aug; 17(6):365-75. PubMed ID: 20429844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metronomic chemotherapy: Back to the future!
    André N; Padovani L; Verschuur A
    Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular targets and cancer therapeutics.
    Westwell AD
    Drug Discov Today; 2004 Dec; 9(24):1042-4. PubMed ID: 15582792
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeutics.
    Reddy LH; Bazile D
    Adv Drug Deliv Rev; 2014 May; 71():34-57. PubMed ID: 24184489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of tumor vascular architecture in drug delivery.
    Narang AS; Varia S
    Adv Drug Deliv Rev; 2011 Jul; 63(8):640-58. PubMed ID: 21514334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J; Schätzlein AG
    Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Special delivery" to cancer cells.
    Fefer A
    Blood; 2002 Mar; 99(5):1503-4. PubMed ID: 11861259
    [No Abstract]   [Full Text] [Related]  

  • 39. Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery.
    Xiong XB; Falamarzian A; Garg SM; Lavasanifar A
    J Control Release; 2011 Oct; 155(2):248-61. PubMed ID: 21621570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical Technology Innovation Strategy Based on the Function of Blood Transport Proteins as DDS Carriers for the Treatment of Intractable Disorders and Cancer.
    Taguchi K
    Biol Pharm Bull; 2020; 43(12):1815-1822. PubMed ID: 33268699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.